Brief Description:This position resides in New Product Planning-Partnerships, reporting directly to the Head of New Product Planning-Partnerships, and will partner directly with Corporate Development, Search & Evaluation, and NPP colleagues to identify and assess the EUR/INT commercial potential and strategic fit of target assets. The role involves collaborating with EUR/INT and Global leadership on portfolio and market access strategy. This individual will work through each step of the deal process, from initiation to signing, ensuring that strategic and critical success factors for EUR/INT commercialization are identified. The person must collect and synthesize multiple layers of evidence and insight from a range of sources and across multiple European and international geographies to assess the potential value of a compound or technology. Jazz is committed to long-term growth associated with mergers, acquisitions, and partnerships; therefore, the position requires a self-motivated, strategically agile, and unquestioned collaborator to join the New Product Planning-Partnerships team.Essential FunctionsLead commercial assessments (e.g., epidemiology, product positioning and adoption, competitive landscape, pricing, and market access) for a wide range of therapeutic areas across 7 key EUR/INT markets (UK, DE, FR, SP, IT, JP, and partnered markets) for partnerships, licenses, and acquisitions.Partner closely and collaboratively with many functions, such as US/EU Commercial, Search and Evaluation, R&D, Regulatory, and Corporate Development for deal assessments and diligence.Gather input for all EUR/INT and global deals (neuroscience and oncology) across key EUR/INT stakeholders in marketing, medical, pricing/access, regulatory, and regional general management roles to inform the commercial business case.Gain internal stakeholder alignment and input on deals through regular (monthly or more frequently as needed) updates to a subset of the EUR/INT Leadership team.Develop detailed annual revenue forecasts extending over a 15-20 year period, and presentations to communicate key inputs, assumptions, and scenarios.Evaluate commercial synergies and strategic fit with the EUR/INT portfolio, including sales force and SG&A requirements.Develop executive-level presentations and recommendations to senior management for required commercial investment, including marketing, sales, and managed markets.Required Knowledge, Skills, and AbilitiesExperiences required for success:Superb analytic skills, especially those related to forecasting/modeling.Track record assessing the clinical and commercial value of an asset in Europe and/or Japan utilizing KOL and internal clinical opinion, published scientific literature, primary market research, syndicated reports, and various audits.Proven track record interfacing and influencing senior leaders and cross-functional collaboration.Following experiences considered a significant plus:Experience leading a commercialization planning effort for a near-term development or in-line product.Experience interfacing with key customers including doctors, payers, and patients.Experience with external business development initiatives.Experience in commercial functions supporting European markets or Japan, such as commercial development, portfolio strategy, pricing/market access, or marketing.Deal transaction familiarity.Required/Preferred Education and Licenses7+ years in management consulting or industry, or a combination of relevant experience.Bachelors in life science and MBA strongly preferred.Advanced science degree highly valued.
#J-18808-Ljbffr